Australia's largest stock trading and investment forum Australia's #1 stock forum

VXL

Click for more information

0.00%

11.5¢ valence industries limited

something like this right? http://en.wikipedia.org/wiki/Greenshoe

First 52 Last

Share
Profile

Follow
beauson45

107 Posts.

23/09/14

05:00

Post #: 14012770
Share

Originally posted by m0ngy ↑

"Simple fact, the major SH's have seen value at 70c"

ausheds It's more complicated than that mate. The underwriters don't need to see the value of the issue price because they can't lose money.
When a public offering trades below its offering price, the offering is said to have "broke issue" and this can lead to further selling and less buying of the shares. To manage this situation, the underwriters oversell ("short") the offering to their clients by an additional 15%- 20% of the offering size. This gives them a lot of capacity to buy back the shares to cover their short. The effect of that short covering is to raise the SP. The downside is that when the short covering is finished the SP falls - in effect the risk is transferred from the underwriter to the unsuspecting investor. So if the VXL SP continues to fall below the issue price we can expect this process to kick in and the SP will rise after the issue date, as the short covering is underway. After the underwriters short covering is complete we will see the 'true value' of the shares.

Expand

something like this right?
http://en.wikipedia.org/wiki/Greenshoe

VXL Price at posting: 69.0¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

BUX

Buxton projects new graphite province discovery at WA Narryer play

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

There are more pages in this discussion • 5 more messages in this thread...

First 52 Last

Add VXL (ASX) to my watchlist